The combination of chemotherapy and intraperitoneal MegaFas Ligand improves treatment of ovarian carcinoma
Anne-Lise Etter, Marc Dupuis, Stéphane Germain(Inserm), Jean-François Delaloye(University Hospital of Lausanne), J Tschopp(University of Lausanne), Isabelle Bassi, B SORDAT
Cited by 20
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
|Science|1996|1.3k
First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
|Breast Cancer Research and Treatment|2016|264
Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand.
|The Journal of Experimental Medicine|1996|136
Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation.
|Journal of Clinical Investigation|1996|127